
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Vaccine-induced immune thrombotic thrombocytopenia
Frederikus A. Klok, Menaka Pai, Menno V. Huisman, et al.
The Lancet Haematology (2021) Vol. 9, Iss. 1, pp. e73-e80
Open Access | Times Cited: 92
Frederikus A. Klok, Menaka Pai, Menno V. Huisman, et al.
The Lancet Haematology (2021) Vol. 9, Iss. 1, pp. e73-e80
Open Access | Times Cited: 92
Showing 1-25 of 92 citing articles:
Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape
Natalie I Mazur, Jonne Terstappen, Ranju Baral, et al.
The Lancet Infectious Diseases (2022) Vol. 23, Iss. 1, pp. e2-e21
Open Access | Times Cited: 284
Natalie I Mazur, Jonne Terstappen, Ranju Baral, et al.
The Lancet Infectious Diseases (2022) Vol. 23, Iss. 1, pp. e2-e21
Open Access | Times Cited: 284
Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review
Yhojan Rodríguez, Manuel Rojas, Santiago Beltrán, et al.
Journal of Autoimmunity (2022) Vol. 132, pp. 102898-102898
Open Access | Times Cited: 81
Yhojan Rodríguez, Manuel Rojas, Santiago Beltrán, et al.
Journal of Autoimmunity (2022) Vol. 132, pp. 102898-102898
Open Access | Times Cited: 81
Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)
Dvir Gatt, Isaac Martín de Diego, Rawan AlFouzan, et al.
Pathogens (2023) Vol. 12, Iss. 2, pp. 154-154
Open Access | Times Cited: 53
Dvir Gatt, Isaac Martín de Diego, Rawan AlFouzan, et al.
Pathogens (2023) Vol. 12, Iss. 2, pp. 154-154
Open Access | Times Cited: 53
Baseline factors associated with self-reported disease flares following COVID-19 vaccination among adults with systemic rheumatic disease: results from the COVID-19 global rheumatology alliance vaccine survey
Lisa G. Rider, Christine G. Parks, Jesse Wilkerson, et al.
Lara D. Veeken (2022) Vol. 61, Iss. SI2, pp. SI143-SI150
Open Access | Times Cited: 59
Lisa G. Rider, Christine G. Parks, Jesse Wilkerson, et al.
Lara D. Veeken (2022) Vol. 61, Iss. SI2, pp. SI143-SI150
Open Access | Times Cited: 59
NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia
Halina Leung, José Perdomo, Zohra Ahmadi, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 59
Halina Leung, José Perdomo, Zohra Ahmadi, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 59
Epidemiology of VITT
Menaka Pai
Seminars in Hematology (2022) Vol. 59, Iss. 2, pp. 72-75
Open Access | Times Cited: 42
Menaka Pai
Seminars in Hematology (2022) Vol. 59, Iss. 2, pp. 72-75
Open Access | Times Cited: 42
COVID-19 Vaccines and Autoimmune Hematologic Disorders
María Eva Mingot‐Castellano, Nora Butta, Mariana Canaro, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 961-961
Open Access | Times Cited: 42
María Eva Mingot‐Castellano, Nora Butta, Mariana Canaro, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 961-961
Open Access | Times Cited: 42
Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT)
Nadia Gabarin, Donald M. Arnold, Ishac Nazy, et al.
Seminars in Hematology (2022) Vol. 59, Iss. 2, pp. 89-96
Open Access | Times Cited: 39
Nadia Gabarin, Donald M. Arnold, Ishac Nazy, et al.
Seminars in Hematology (2022) Vol. 59, Iss. 2, pp. 89-96
Open Access | Times Cited: 39
COVID-19 Vaccines: Where Did We Stand at the End of 2023?
Kenneth Lundström
Viruses (2024) Vol. 16, Iss. 2, pp. 203-203
Open Access | Times Cited: 10
Kenneth Lundström
Viruses (2024) Vol. 16, Iss. 2, pp. 203-203
Open Access | Times Cited: 10
Incidence and management of the main serious adverse events reported after COVID ‐19 vaccination
Teresa Padilla‐Flores, Alicia Sampieri, Luis Vaca
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 3
Open Access | Times Cited: 9
Teresa Padilla‐Flores, Alicia Sampieri, Luis Vaca
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 3
Open Access | Times Cited: 9
Treatment of drug-induced immune thrombocytopenias
Irene Marini, Günalp Uzun, Kinan Jamal, et al.
Haematologica (2022) Vol. 107, Iss. 6, pp. 1264-1277
Open Access | Times Cited: 38
Irene Marini, Günalp Uzun, Kinan Jamal, et al.
Haematologica (2022) Vol. 107, Iss. 6, pp. 1264-1277
Open Access | Times Cited: 38
Cerebral Venous Sinus Thrombosis Following COVID-19 Vaccination: A Systematic Review
Vikash Jaiswal, Gaurav Nepal, Patricia Dijamco, et al.
Journal of Primary Care & Community Health (2022) Vol. 13
Open Access | Times Cited: 35
Vikash Jaiswal, Gaurav Nepal, Patricia Dijamco, et al.
Journal of Primary Care & Community Health (2022) Vol. 13
Open Access | Times Cited: 35
Platelet, a key regulator of innate and adaptive immunity
Cheng Yan, Haojie Wu, Xianchun Fang, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 18
Cheng Yan, Haojie Wu, Xianchun Fang, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 18
COVID-19, Vaccines, and Thrombotic Events: A Narrative Review
Maurizio Giuseppe Abrignani, Adriano Murrone, Leonardo De Luca, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 4, pp. 948-948
Open Access | Times Cited: 27
Maurizio Giuseppe Abrignani, Adriano Murrone, Leonardo De Luca, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 4, pp. 948-948
Open Access | Times Cited: 27
SARS-CoV-2 and COVID-19: A Narrative Review
Andrew D. Blann, Rebekka Heitmar
British Journal of Biomedical Science (2022) Vol. 79
Open Access | Times Cited: 26
Andrew D. Blann, Rebekka Heitmar
British Journal of Biomedical Science (2022) Vol. 79
Open Access | Times Cited: 26
Approach to the Patient With Adrenal Hemorrhage
Yasir Elhassan, Cristina L. Ronchi, Piyumi Wijewickrama, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 108, Iss. 4, pp. 995-1006
Open Access | Times Cited: 26
Yasir Elhassan, Cristina L. Ronchi, Piyumi Wijewickrama, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 108, Iss. 4, pp. 995-1006
Open Access | Times Cited: 26
COVID-19 and antiphospholipid antibodies
Ayesha Butt, Doruk Erkan, Alfred Ian Lee
Best Practice & Research Clinical Haematology (2022) Vol. 35, Iss. 3, pp. 101402-101402
Open Access | Times Cited: 24
Ayesha Butt, Doruk Erkan, Alfred Ian Lee
Best Practice & Research Clinical Haematology (2022) Vol. 35, Iss. 3, pp. 101402-101402
Open Access | Times Cited: 24
COVID-19 Vaccination in Korea
Wan Beom Park, Young Hoon Hwang, Hee Jin Cheong
Infection and Chemotherapy (2023) Vol. 55, Iss. 1, pp. 135-135
Open Access | Times Cited: 15
Wan Beom Park, Young Hoon Hwang, Hee Jin Cheong
Infection and Chemotherapy (2023) Vol. 55, Iss. 1, pp. 135-135
Open Access | Times Cited: 15
New perspectives on the induction and acceleration of immune-associated thrombosis by PF4 and VWF
Zhiyan Liu, Min-Xue Sun, Man-Qi Hua, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Zhiyan Liu, Min-Xue Sun, Man-Qi Hua, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Mucosal immunization with a low-energy electron inactivated respiratory syncytial virus vaccine protects mice without Th2 immune bias
Valentina Eberlein, Sophia Rosencrantz, Julia Finkensieper, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Valentina Eberlein, Sophia Rosencrantz, Julia Finkensieper, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination
Shinya Yamada, Hidesaku Asakura
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3338-3338
Open Access | Times Cited: 21
Shinya Yamada, Hidesaku Asakura
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3338-3338
Open Access | Times Cited: 21
Ischemic Stroke and Vaccine-Induced Immune Thrombotic Thrombocytopenia following COVID-19 Vaccine: A Case Report with Systematic Review of the Literature
Angelo Cascio Rizzo, Giuditta Giussani, Elio Clemente Agostoni
Cerebrovascular Diseases (2022) Vol. 51, Iss. 6, pp. 722-734
Open Access | Times Cited: 21
Angelo Cascio Rizzo, Giuditta Giussani, Elio Clemente Agostoni
Cerebrovascular Diseases (2022) Vol. 51, Iss. 6, pp. 722-734
Open Access | Times Cited: 21
Potential mechanisms of vaccine-induced thrombosis
Marco Marietta, Valeria Coluccio, Mario Luppi
European Journal of Internal Medicine (2022) Vol. 105, pp. 1-7
Open Access | Times Cited: 21
Marco Marietta, Valeria Coluccio, Mario Luppi
European Journal of Internal Medicine (2022) Vol. 105, pp. 1-7
Open Access | Times Cited: 21
Humoral immunity to SARS-CoV-2 elicited by combination COVID-19 vaccination regimens
Zijun Wang, Frauke Muecksch, Friederike Muenn, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 10
Open Access | Times Cited: 21
Zijun Wang, Frauke Muecksch, Friederike Muenn, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 10
Open Access | Times Cited: 21
SARS-CoV-2 vaccination and new-onset myasthenia gravis: A report of 7 cases and review of the literature
Sithara Ramdas, Ryan Hum, Abigail Price, et al.
Neuromuscular Disorders (2022) Vol. 32, Iss. 10, pp. 785-789
Open Access | Times Cited: 21
Sithara Ramdas, Ryan Hum, Abigail Price, et al.
Neuromuscular Disorders (2022) Vol. 32, Iss. 10, pp. 785-789
Open Access | Times Cited: 21